含孕激素宫内节育器 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "含孕激素宫内节育器" in Chinese language version.

refsWebsite

Global rank Chinese rank

7web.archive.org

1^st place

4books.google.com

3^rd place

8^th place

1archive.org

6^th place

4^th place

1worldcat.org

5^th place

12^th place

1contraceptivetechnology.org

low place

1drugs.com

399^th place

208^th place

1who.int

195^th place

179^th place

1msh.org

low place

2,351^st place

archive.org

British national formulary: BNF 69 69th. British Medical Association. 2015: 556. ISBN 9780857111562.

books.google.com

Wipf, Joyce. Women's Health, An Issue of Medical Clinics of North America,. Elsevier Health Sciences. 2015: 507 [2017-09-26]. ISBN 9780323376082. （原始内容存档于2019-06-05）.
Bradley, Linda D.; Falcone, Tommaso. Hysteroscopy: Office Evaluation and Management of the Uterine Cavity. Elsevier Health Sciences. 2008: 171 [2017-09-26]. ISBN 0323041019. （原始内容存档于2019-07-30）.
Zieman, Mimi. Chapter 27. Managing Contraception 2012–2014. Managing Contraception. [2017-09-26]. ISBN 9781467536400. （原始内容存档于2020-08-03）.
Schäfer-Korting, Monika. Drug Delivery. Springer Science & Business Media. 2010: 290 [2017-09-26]. ISBN 9783642004773. （原始内容存档于2019-06-09）.

contraceptivetechnology.org

Trussell, James. Contraceptive efficacy. Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.) (编). Contraceptive technology 20th revised. New York: Ardent Media. 2011: 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. （页面存档备份，存于互联网档案馆）

drugs.com

Levonorgestrel intrauterine system medical facts from Drugs.com. www.drugs.com. [1 January 2017]. （原始内容存档于2017-01-01）.

msh.org

erc.msh.org

IUD (Levonorgestrel). International Drug Price Indicator Guide. [8 December 2016]. ^{[永久失效連結]}

web.archive.org

Trussell, James. Contraceptive efficacy. Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.) (编). Contraceptive technology 20th revised. New York: Ardent Media. 2011: 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. （页面存档备份，存于互联网档案馆）
Levonorgestrel intrauterine system medical facts from Drugs.com. www.drugs.com. [1 January 2017]. （原始内容存档于2017-01-01）.
Wipf, Joyce. Women's Health, An Issue of Medical Clinics of North America,. Elsevier Health Sciences. 2015: 507 [2017-09-26]. ISBN 9780323376082. （原始内容存档于2019-06-05）.
Bradley, Linda D.; Falcone, Tommaso. Hysteroscopy: Office Evaluation and Management of the Uterine Cavity. Elsevier Health Sciences. 2008: 171 [2017-09-26]. ISBN 0323041019. （原始内容存档于2019-07-30）.
WHO Model List of Essential Medicines (19th List) (PDF). World Health Organization. April 2015 [8 December 2016]. （原始内容存档 (PDF)于2016-12-13）.
Zieman, Mimi. Chapter 27. Managing Contraception 2012–2014. Managing Contraception. [2017-09-26]. ISBN 9781467536400. （原始内容存档于2020-08-03）.
Schäfer-Korting, Monika. Drug Delivery. Springer Science & Business Media. 2010: 290 [2017-09-26]. ISBN 9783642004773. （原始内容存档于2019-06-09）.

who.int

WHO Model List of Essential Medicines (19th List) (PDF). World Health Organization. April 2015 [8 December 2016]. （原始内容存档 (PDF)于2016-12-13）.

worldcat.org

Trussell, James. Contraceptive efficacy. Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.) (编). Contraceptive technology 20th revised. New York: Ardent Media. 2011: 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. （页面存档备份，存于互联网档案馆）